Norpace®
Back to Test Catalogue
Disopyramide, Serum/Plasma
Test ID: DISOP
Test
Aliases/Synonyms
Method
Immunoassay
Report Includes
Disopyramide
Specimens
Avoid gel separator tubes; Serum; Plasma (Heparin); Plasma (EDTA)
Clinical Utility
Disopyramide is useful in treating patients with cardiac arrhythmias and tachcardia. Therapeutic drug monitoring is useful to optimize dose and avoid toxicity.
Test Version
20-Nov-2019
Specimen
Specimens
Avoid gel separator tubes; Serum; Plasma (Heparin); Plasma (EDTA)
Collection Containers
Preferred
Serum (red top)
Acceptable
Plasma sodium heparin green top; Plasma EDTA lavender top
Sample Volume
1 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Centrifuge and immediately separate serum or plasma specimens from the cells.
Stability
| Ambient | 5 days |
|---|---|
| Refrigerated | 14 days |
| Frozen | 35 days |
Rejection Criteria
| Specimen | Gel-separator |
|---|
Test Version
20-Nov-2019
Performance / Interpretation
Method
Immunoassay
Turnaround Time
7 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Disopyramide | mg/L |
|
||
Test Version
20-Nov-2019
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| DISOP | 62201DISOPYRAMIDE | mg/L |
Test Version
20-Nov-2019